Biotechnology Companies
And the 2006 winners of the biotechnology Fierce 15 are...
(click a company to read its profile)
|
|
|
|
If you look over the biotechnology companies on this year's list, you'll see a few common attributes: There's a big emphasis on efficient use of capital; more of these up-and-coming biotechs are striking licensing deals with major pharma partners at an earlier stage than ever; and the valuations they appear to be getting are strong.
If you've got good science, there's never been a better time to be a biotechnology company.
Over the rest of the year, many of these biotechnology companies will be back in FierceBiotech's daily newsletter with new licensing deals, a move to go public or, in some cases, news they are being bought out. They'll be back in the news because the technology that they founded their business on promises to produce real advances for hard-to-treat medical conditions. Some are working with legendary scientists; others are promising to become the legends of the future. No doubt, a few might fail to live up to their early potential. But with the biotechnology industry steadily gaining ground with new medicines, they all have a better chance at making the grade than ever before. We'll be watching this group closely, of course, as with all of the Fierce 15 alum of the past four years. -John Carroll
|
